Alvit LCS Pharma Overview
Alvit LCS Pharma is a vertically integrated medical cannabis research and development company specializing in pharmaceutical-grade cannabis product development and drug-delivery technologies. The company's products include various types of tablets, sprays, and suppositories. Alvit controls the entire lifecycle of the cannabis drug-development process, including Good Agriculture Practice-controlled cultivation of proprietary cannabis clones, standardized extracts, preclinical evaluations, proprietary formulations, and first-in-human studies. In November 2018, Alvit LCS Pharma announced the merger of its cannabis growing activity into Intelicann, a cannabis cultivation facility in Israel that is publicly traded on the Tel Aviv Stock Exchange.
Cumulative Funding Raised Over Time ($)
—Jan 2017
Latest News
Alvit: Europe's search for cannabis flowers comes to an end
Cannabis-based products in a language doctors understand
growth-positive
Alvit LCS Pharma Sponsors Cannabis Pavilion in Davos
Alvit LCS Pharma, a medical cannabis company, is a sponsor of Cannatechs Canada Cannabis House in Davos. The CEO presented at the event and expressed the companys commitment to nurturing key relationships and showcasing their products and technologies. The Canada Cannabis House pavilion includes notable presenters and attendees from the cannabis industry. Alvit LCS Pharma specializes in pharma grade products and drug delivery technologies, with a focus on standardized cannabis extracts that have undergone clinical trials. The company aims to provide doctors with the knowledge they need to effectively prescribe cannabis to patients.
PartnersCustomers
growth-positive
Alvit LCS Pharma: Manufacturing and Licensing Agreement With Israel's Largest Medical Cannabis Company Bazelet
Bazelet, Israels largest Medical Cannabis Company, has signed a manufacturing and licensing agreement with Alvit LCS Pharma to manufacture, market, and sell Alvits line of pharma grade medical cannabis products in Israel and the EU. Bazelet will also collaborate with Alvit on the research and development of a new pharmaceutical drug for the treatment of Inflammatory Bowel Disease (IBD). This partnership strengthens Bazelets position in the Israeli Medical Cannabis market and expands its product offerings. Bazelets CEO, Meir Ariel, expressed excitement about the agreement and the potential benefits for patients. Alvit, an international leader in the development of products based on standardized cannabis extracts, will work with Bazelet to manufacture and distribute their products and develop an IBD product based on Bazelets unique API.
Partners
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | Undisclosed |
| Last funding | Undisclosed |
| Stage | Mature |
| Rounds | 1 |
| Investors | 1 |
Team Members
4
Employees: 1-10
Web & Social Links
| Website | www.alvitpharma.com/ |
Locations
Yigal Alon 94, Tel-Aviv, Israel
Photos & Videos
2 item(s)
Alvit LCS Pharma Business
Business models
B2B
Product stage
Released
Employees
1-10
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyMedical CannabisTarget Customer
Healthcare & Life SciencesLife SciencesPharmaceuticalsCore Technology
Materials & SubstancesRaw MaterialsTags (5)
medical-cannabispharmaceuticalsdrug-deliverypatientscannabisGeographic Markets
GermanyCanadaSouth AmericaUnited StatesEuropeIsraelThailandMaltaPortugalAlvit LCS Pharma Financials
Undisclosed
Total funding
Undisclosed
Capital raised
Undisclosed
Last funding
Mature
Funding stage
1
Total rounds
1
Investors
Cumulative Funding Raised Over Time ($)
—Jan 2017
Private Equity Funding
Undisclosed Round
Jan 2017
Undisclosed
Oded Zucker
Alvit LCS Pharma Lifecycle
Cumulative Funding Raised Over Time
—Jan 2017
All Events
Undisclosed Round
Jan 2017
Undisclosed
Oded Zucker
Alvit LCS Pharma News
4 articlesAlvit: Europe's search for cannabis flowers comes to an end
Cannabis-based products in a language doctors understand
growth-positive
Alvit LCS Pharma Sponsors Cannabis Pavilion in Davos
Alvit LCS Pharma, a medical cannabis company, is a sponsor of Cannatechs Canada Cannabis House in Davos. The CEO presented at the event and expressed the companys commitment to nurturing key relationships and showcasing their products and technologies. The Canada Cannabis House pavilion includes notable presenters and attendees from the cannabis industry. Alvit LCS Pharma specializes in pharma grade products and drug delivery technologies, with a focus on standardized cannabis extracts that have undergone clinical trials. The company aims to provide doctors with the knowledge they need to effectively prescribe cannabis to patients.
PartnersCustomers
growth-positive
Alvit LCS Pharma: Manufacturing and Licensing Agreement With Israel's Largest Medical Cannabis Company Bazelet
Bazelet, Israels largest Medical Cannabis Company, has signed a manufacturing and licensing agreement with Alvit LCS Pharma to manufacture, market, and sell Alvits line of pharma grade medical cannabis products in Israel and the EU. Bazelet will also collaborate with Alvit on the research and development of a new pharmaceutical drug for the treatment of Inflammatory Bowel Disease (IBD). This partnership strengthens Bazelets position in the Israeli Medical Cannabis market and expands its product offerings. Bazelets CEO, Meir Ariel, expressed excitement about the agreement and the potential benefits for patients. Alvit, an international leader in the development of products based on standardized cannabis extracts, will work with Bazelet to manufacture and distribute their products and develop an IBD product based on Bazelets unique API.
Partners
Alvit LCS Pharma Team
Employee Info
| Employees (range) | 1-10 |
| Exact count | 4 |
| Team members | 4 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 8 classification IDs that could be used for matching.
Alvit LCS Pharma Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 88/100 |
| Missing | not claimed |
| BI Verification | Yotam Maman |
| Registrar ID | 515072056 |
| Crunchbase | alvit-lcs-pharma |
| Creator | Hilla Gorokhovsky |
| Creator email | hilla.gorokhovsky@sncentral.org |
| Last updater | Orli Wollner |
| Updater email | orlushka@gmail.com |
| Last update | 2020-10-06T00:00:00.000Z |
| Created | 2019-04-11T00:00:00.000Z |